Antibody-drug conjugates in HER-2 negative breast cancers with poor prognosis

Püsküllüoglu, M; Rudzi, A; Pacholczak-Madej, R

Püsküllüoglu, M (通讯作者),Maria Sklodowska Curie Natl Res Inst Oncol, Dept Clin Oncol, Krakow Branch, Garncarska St 11, PL-31115 Krakow, Poland.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023; 1878 (6):

Abstract

Antibody drug conjugates (ADCs) comprise a rapidly growing class of targeted drugs that selectively deliver a cytotoxic agent to cancer cells, reducin......

Full Text Link